课题基金 / 基金详情

The predictive utility of placental growth factor testing between 26 and 28 weeks in screening for preterm delivery due to placenta-mediated complications: A prospective cohort study in 5,000 apparently low-risk pregnancies

The predictive utility of placental growth factor testing between 26 and 28 weeks in screening for preterm delivery due to placenta-mediated complications: A prospective cohort study in 5,000 apparently low-risk pregnancies
26 至 28 周胎盘生长因子检测在筛查因胎盘介导的并发症引起的早产方面的预测效用：一项针对 5,000 例明显低风险妊娠的前瞻性队列研究
批准号：
486451
负责人：
Gladstone Rachel A
金额：
$1.27万
依托单位：
University of Toronto
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486451&lang=en
关键词：
Hypertension Placental Growth Factor Pre-Eclampsia Pregnancy Prevention

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
先兆子痫是一种潜在的危及生命的妊娠并发症，可引起血压升高并损伤重要器官。它与胎盘的异常发育和进行性损伤密切相关。这种病无药可治
英文摘要
Pre-eclampsia is a potentially life-threatening pregnancy complication, causing elevated blood pressure with injury to important organs. It is strongly associated with abnormal development of and progressive damage to the placenta. There is no cure for th
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金